Drug Details
| General Information of the Drug (ID: DR3439) | ||||
|---|---|---|---|---|
| Name |
Apatinib
|
|||
| Synonyms |
Apatinib mesylate; VEGF receptor inhibitor (cancer), Advenchen; VEGFR2 receptor inhibitor (cancer), LSK/ Jiangsu Henrui/ Bukwang
Click to Show/Hide
|
|||
| Molecular Type |
Small molecule
|
|||
| Disease | Breast cancer [ICD-11: 2C60] | Approved | [1] | |
| Structure |
|
Click to Download Mol2D MOL |
||
| Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | ||||
| Formula |
C24H23N5O
|
|||
| PubChem CID | ||||
| Canonical SMILES |
C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4
|
|||
| InChI |
1S/C24H23N5O/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)29-23(30)21-4-3-13-27-22(21)28-16-18-9-14-26-15-10-18/h3-10,13-15H,1-2,11-12,16H2,(H,27,28)(H,29,30)
|
|||
| InChIKey |
WPEWQEMJFLWMLV-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 811803-05-1
|
|||
| GDSC | ||||
| TTD Drug ID | ||||
| DrugBank ID | ||||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. A List of Natural Product(s) Able to Enhance the Efficacy of This Drug | ||||||
| Celastrol | Celastrus strigillosus | Click to Show/Hide the Molecular Data of This NP | ||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [2] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| Molecule(s)
Regulation |
Down-regulation | Phosphorylation | AKT1 | Molecule Info |
Pathway MAP
|
|
| Up-regulation | Expression | BAX | Molecule Info |
Pathway MAP
|
||
| Up-regulation | Cleavage | CASP3 | Molecule Info |
Pathway MAP
|
||
| Down-regulation | Phosphorylation | ERK1 | Molecule Info |
Pathway MAP
|
||
| In-vitro Model | Hep 3B2.1-7 | CVCL_0326 | Childhood hepatocellular carcinoma | Homo sapiens | ||
| Experimental
Result(s) |
The combination of Apatinib and Tripterine significantly inhibited the proliferation, migration and invasion ability and promoted the apoptosis of Hep3B cells by downregulating the expression of p-Akt and p-ERK, and upregulating the expression of Caspase-3 and Bax. | |||||
| Cordycepin | Prunus persica | Click to Show/Hide the Molecular Data of This NP | ||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [3] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| Molecule(s)
Regulation |
Down-regulation | Phosphorylation | AKT1 | Molecule Info |
Pathway MAP
|
|
| Up-regulation | Expression | BAX | Molecule Info |
Pathway MAP
|
||
| Down-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
||
| Up-regulation | Cleavage | CASP3 | Molecule Info |
Pathway MAP
|
||
| Down-regulation | Phosphorylation | PIK3CB | Molecule Info |
Pathway MAP
|
||
| Down-regulation | Expression | VEGFA | Molecule Info |
Pathway MAP
|
||
| In-vitro Model | A-549 | CVCL_0023 | Lung adenocarcinoma | Homo sapiens | ||
| PC-9 | CVCL_B260 | Lung adenocarcinoma | Homo sapiens | |||
| Experimental
Result(s) |
Combination of cordycepin and apatinib synergistically inhibits NSCLC cells by down-regulating VEGF/PI3K/Akt signaling pathway. | |||||
| Schisandrol B | Schisandra chinensis | Click to Show/Hide the Molecular Data of This NP | ||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [4] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| Molecule(s)
Regulation |
Up-regulation | Expression | BAX | Molecule Info |
Pathway MAP
|
|
| Up-regulation | Cleavage | CASP9 | Molecule Info |
Pathway MAP
|
||
| Down-regulation | Expression | MMP-9 | Molecule Info |
Pathway MAP
|
||
| In-vitro Model | SGC-7901 | CVCL_0520 | Human gastric cancer | Homo sapiens | ||
| Experimental
Result(s) |
Low-toxicity Sch.B combined with low dosage apatinib has a more potent anti-cancer effect that apatinib alone. | |||||
| Target and Pathway | ||||
|---|---|---|---|---|
| Target(s) | Vascular endothelial growth factor receptor 2 (KDR) | Molecule Info | [5] | |
| KEGG Pathway | Ras signaling pathway | Click to Show/Hide | ||
| 2 | Rap1 signaling pathway | |||
| 3 | Cytokine-cytokine receptor interaction | |||
| 4 | Endocytosis | |||
| 5 | PI3K-Akt signaling pathway | |||
| 6 | VEGF signaling pathway | |||
| 7 | Focal adhesion | |||
| 8 | Proteoglycans in cancer | |||
| NetPath Pathway | IL2 Signaling Pathway | Click to Show/Hide | ||
| Panther Pathway | Angiogenesis | Click to Show/Hide | ||
| 2 | VEGF signaling pathway | |||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | Click to Show/Hide | ||
| 2 | Beta3 integrin cell surface interactions | |||
| 3 | Signaling events mediated by TCPTP | |||
| 4 | SHP2 signaling | |||
| 5 | S1P1 pathway | |||
| 6 | VEGF and VEGFR signaling network | |||
| 7 | Integrins in angiogenesis | |||
| 8 | Signaling events mediated by VEGFR1 and VEGFR2 | |||
| 9 | Notch-mediated HES/HEY network | |||
| Reactome | Neurophilin interactions with VEGF and VEGFR | Click to Show/Hide | ||
| 2 | VEGF binds to VEGFR leading to receptor dimerization | |||
| 3 | Integrin cell surface interactions | |||
| 4 | EPHA-mediated growth cone collapse | |||
| 5 | VEGFA-VEGFR2 Pathway | |||
| 6 | VEGFR2 mediated cell proliferation | |||
| WikiPathways | Focal Adhesion | Click to Show/Hide | ||
| 2 | Nifedipine Activity | |||
| 3 | Cardiac Progenitor Differentiation | |||
| 4 | Signaling by VEGF | |||
| 5 | Angiogenesis | |||
